HCA Healthcare: Undervalued by 47%, Fair Value Estimated at $900

HCA Healthcare's estimated fair value is $900, suggesting the company is potentially 47% undervalued with a current share price of $479. The $486 analyst price target is 46% less than the estimated fair value. The two-stage DCF model takes into account two stages of growth, with the first stage being a higher growth period and the second stage being a steady growth period. The model estimates the next ten years of cash flows and discounts them to today's value.